006280.KS - GC Biopharma Corp.
GC Biopharma Corp.
107, Ihyeon-ro 30beon-gil
Giheung-gu
Yongin-Si
South Korea
82 3 1260 9300
https://www.globalgreencross.com
Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full-time employees:
Key executives
| Name | Title | Pay | Exercised | Year born |
|---|---|---|---|---|
| Mr. Il-Sup Huh Ph.D. | Chairman & CEO | N/A | N/A | 1954 |
| Mr. Eun-Cheol Hur | Pres & Director | N/A | N/A | 1972 |
| Mr. Min-Taek Lee | Sr. Managing Director of Sales | N/A | N/A | 1963 |
| Mr. Young Sup Huh | Exec. VP | N/A | N/A | 1941 |
| Mr. In-Jae Lee | Sr. MD & Director | N/A | N/A | 1963 |
| Mr. Byeong-Hwa Kim | VP & Director | N/A | N/A | 1958 |
Description
GC Biopharma Corp., a biopharmaceutical company, develops drugs and vaccines in South Korea. The company provides plasma derivatives, including albumin, immunoglobulin, and antithrombin; and vaccines for hepatitis-B, Hantavirus hemorrhagic fever, influenza, flu, and varicella. It also offers prescription drugs for the bleeding symptom control and hemostasis for persons with hemophilia A; prevention and treatment of bleeding episodes induced by hemophilia A and post-operative treatment; and treatment of neutropenia, hunter syndrome, and liver cancer, as well as treatment of anti-inflammation, pain relief, and osteoarthritis. In addition, the company provides over the counter drugs. It also exports its products to approximately 50 countries. The company has a licensing and collaboration agreement with Tottori University for development of GM1 gangliosidosis chaperone therapy. GC Biopharma Corp. was founded in 1967 and is headquartered in Yongin-si, South Korea. GC Biopharma Corp. is a subsidiary of Green Cross Holdings Corporation.
Corporate governance
GC Biopharma Corp.’s ISS governance QualityScore as of 1 June 2023 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder rights: 7; Compensation: 9.
